Collection of Blood Specimens From Patients in AL-3789 Studies for Elevated Intraocular Pressure (IOP)

This study has been completed.
Sponsor:
Information provided by:
Alcon Research
ClinicalTrials.gov Identifier:
NCT00691639
First received: June 3, 2008
Last updated: September 30, 2009
Last verified: September 2009
  Purpose

The objective of this study is to obtain blood samples from patients who are or were participants in any Alcon AL-3789 clinical trial. Association will be conducted to search for genetic markers in patients with glaucoma or ocular hypertension.


Condition Intervention
Open-Angle Glaucoma
Other: Blood Collection Only

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Collection of Blood Specimens From Patients in AL-3789 Studies for Elevated Intraocular Pressure (IOP)

Resource links provided by NLM:


Further study details as provided by Alcon Research:

Estimated Enrollment: 1000
Study Start Date: March 2008
Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
1
Patients who are or were participants in any Alcon AL-3789 study.
Other: Blood Collection Only
Blood Collection Only

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients who received anecortave acetate treatment

Criteria

Inclusion Criteria:

  • Patient must be currently or previously enrolled in Alcon clinical study and received AL-3789

Exclusion Criteria:

  • Age related
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00691639

Locations
United States, Texas
Alcon Call Center
Fort Worth, Texas, United States, 76134
Sponsors and Collaborators
Alcon Research
  More Information

No publications provided

Responsible Party: Alberta Davis, Alcon
ClinicalTrials.gov Identifier: NCT00691639     History of Changes
Other Study ID Numbers: C-07-27
Study First Received: June 3, 2008
Last Updated: September 30, 2009
Health Authority: United States: Food and Drug Administration

Keywords provided by Alcon Research:
Open-angle glaucoma
IOP

Additional relevant MeSH terms:
Glaucoma
Glaucoma, Open-Angle
Ocular Hypertension
Eye Diseases

ClinicalTrials.gov processed this record on July 26, 2014